Search - tctmd.com

Displaying 1 - 20 of 105

Sort: Relevancy | Date

News Conference News AHA 2017

‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry

Todd Neale

November 22, 2017

News Conference News TCT 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Todd Neale

November 02, 2017

Presentation TCT 2017

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Presenter: Samir R. Kapadia, David J. Moliterno

November 01, 2017

Presentation TCT 2017

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Presenter: Samir R. Kapadia, Sameer Gafoor

November 01, 2017

Presentation TCT 2017

Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset

Presenter: Samir R. Kapadia, Brian K. Whisenant

November 01, 2017

Presentation TCT 2017

Rationale and Potential Role for LAA Closure in the PCI and ACS Patient

Presenter: Samir R. Kapadia, Ashish Pershad

November 01, 2017

Presentation TCT 2017

Managing AS Patients With Atrial Fibrillation in TAVR Patients Pharmacotherapy Considerations and LAAC Possibilities (WATCH-TAVR Trial)

Presenter: Samir R. Kapadia

November 01, 2017

Presentation TCT 2017

My Most Challenging LAA Closure Case: Twice As Many Problems As Usual

Presenter: Matthew J. Price, Jacqueline Saw, Petr Neuzil

October 31, 2017

Presentation TCT 2017

Medical Treatment After LAA Closure: Trade-off of Bleeding vs Device-Related Thrombus

Presenter: Matthew J. Price, Jacqueline Saw, Lucas V. Boersma

October 31, 2017

Presentation TCT 2017

Residual Leaks After LAA Closure: Frequency, Prevention, and Treatment (With Case Reviews)

Presenter: Matthew J. Price, Jacqueline Saw, Kolja Sievert

October 31, 2017

Presentation TCT 2017

Device Embolization: Frequency, Prevention, and Treatment (With Case Reviews)

Presenter: Matthew J. Price, Jacqueline Saw, Brian K. Whisenant

October 31, 2017

Presentation TCT 2017

Periprocedural Effusions and Tamponade: Frequency, Prevention, and Treatment (With Case Reviews)

Presenter: Matthew J. Price, Jacqueline Saw, Martin W. Bergmann

October 31, 2017

Presentation TCT 2017

Combination Therapies II: When and How to Consider TMVT and LAA Closure

Presenter: Samir R. Kapadia, Karl-Heinz Kuck, Fabian Nietlispach

October 31, 2017

Presentation TCT 2017

PROLIPSIS: Device Description, Data, and Future Directions

Presenter: Mark Reisman, Josep Rodés-Cabau, Eleftherios Sideris

October 31, 2017

Presentation TCT 2017

SeaLA: Device Description, Data, and Future Directions

Presenter: Mark Reisman, Josep Rodés-Cabau, Kolja Sievert

October 31, 2017

Presentation TCT 2017

Occlutech LAA Occluder: Device Description, Data, and Future Directions

Presenter: Mark Reisman, Josep Rodés-Cabau, Kolja Sievert

October 31, 2017

Presentation TCT 2017

WaveCrest: Device Description, Data, and Future Directions

Presenter: Mark Reisman, Josep Rodés-Cabau, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

Ultraseal LAA Occluder: Device Description, Data, and Future Directions

Presenter: Mark Reisman, Josep Rodés-Cabau

October 31, 2017

Presentation TCT 2017

Lambre: Device Description, Data, and Future Directions

Presenter: Mark Reisman, Josep Rodés-Cabau, Yat Sun Joseph Chan

October 31, 2017

Presentation TCT 2017

LARIAT: LAA Occlusion, Electrical Isolation, or Both?

Presenter: Mark Reisman, Josep Rodés-Cabau, DJ Lakkireddy

October 31, 2017

Advertisement

‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset

Rationale and Potential Role for LAA Closure in the PCI and ACS Patient

Managing AS Patients With Atrial Fibrillation in TAVR Patients Pharmacotherapy Considerations and LAAC Possibilities (WATCH-TAVR Trial)

My Most Challenging LAA Closure Case: Twice As Many Problems As Usual

Medical Treatment After LAA Closure: Trade-off of Bleeding vs Device-Related Thrombus

Residual Leaks After LAA Closure: Frequency, Prevention, and Treatment (With Case Reviews)

Device Embolization: Frequency, Prevention, and Treatment (With Case Reviews)

Periprocedural Effusions and Tamponade: Frequency, Prevention, and Treatment (With Case Reviews)

Combination Therapies II: When and How to Consider TMVT and LAA Closure

PROLIPSIS: Device Description, Data, and Future Directions

SeaLA: Device Description, Data, and Future Directions

Occlutech LAA Occluder: Device Description, Data, and Future Directions

WaveCrest: Device Description, Data, and Future Directions

Ultraseal LAA Occluder: Device Description, Data, and Future Directions

Lambre: Device Description, Data, and Future Directions

LARIAT: LAA Occlusion, Electrical Isolation, or Both?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content